NSE:NGLFINE (India)
Â
Shs Dematerialised
₹
3,193.6
-17.7 (-0.55%)
Jul 10
Business Description
NGL Fine-Chem Ltd
ISIN : INE887E01022
Share Class Description:
NSE:NGLFINE: Shs DematerialisedTotal Employee Number:
523Compare
Compare
Traded in other countries / regions
524774.India IPO Date
2022-07-08Description
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | 1.24 | |||||
Interest Coverage | 11.7 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.06 | |||||
Beneish M-Score | -1.17 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.3 | |||||
3-Year EBITDA Growth Rate | 29.9 | |||||
3-Year EPS without NRI Growth Rate | 32.9 | |||||
3-Year Book Growth Rate | 13.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.74 | |||||
9-Day RSI | 58.56 | |||||
14-Day RSI | 59.05 | |||||
3-1 Month Momentum % | 20.62 | |||||
6-1 Month Momentum % | 98.03 | |||||
12-1 Month Momentum % | 113.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.84 | |||||
Quick Ratio | 1.37 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 95.81 | |||||
Days Sales Outstanding | 78.9 | |||||
Days Payable | 98.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.05 | |||||
Dividend Payout Ratio | 0.02 | |||||
Forward Dividend Yield % | 0.05 | |||||
5-Year Yield-on-Cost % | 0.05 | |||||
Shareholder Yield % | -1.73 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.2 | |||||
Operating Margin % | 10.43 | |||||
Net Margin % | 9.59 | |||||
EBITDA Margin % | 17.43 | |||||
FCF Margin % | -9.28 | |||||
OCF Margin % | 8.64 | |||||
ROE % | 15.81 | |||||
ROA % | 9.85 | |||||
ROIC % | 10.99 | |||||
3-Year ROIIC % | 10.05 | |||||
ROC (Joel Greenblatt) % | 20.19 | |||||
ROCE % | 19.29 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 40.91 | |||||
PE Ratio without NRI | 40.91 | |||||
Shiller PE Ratio | 55.86 | |||||
Price-to-Owner-Earnings | 293.74 | |||||
PS Ratio | 3.92 | |||||
PB Ratio | 5.98 | |||||
Price-to-Tangible-Book | 5.95 | |||||
Price-to-Operating-Cash-Flow | 45.37 | |||||
EV-to-EBIT | 30.01 | |||||
EV-to-EBITDA | 23.29 | |||||
EV-to-Revenue | 4.07 | |||||
EV-to-FCF | -43.57 | |||||
Price-to-GF-Value | 1.13 | |||||
Price-to-Projected-FCF | 213.19 | |||||
Price-to-Median-PS-Value | 1.47 | |||||
Price-to-Graham-Number | 3.28 | |||||
| Price-to-Net-Current-Asset-Value | 32.55 | |||||
Earnings Yield (Greenblatt) % | 3.33 | |||||
FCF Yield % | -2.36 | |||||
Forward Rate of Return (Yacktman) % | -4.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NGL Fine-Chem Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 5,011.864 | ||
| EPS (TTM) (₹) | 77.77 | ||
| Beta | 0.7062 | ||
| 3-Year Sharpe Ratio | 0.45 | ||
| 3-Year Sortino Ratio | 0.7 | ||
| Volatility % | 48.9 | ||
| 14-Day RSI | 59.05 | ||
| 14-Day ATR (₹) | 183.04666 | ||
| 20-Day SMA (₹) | 3084.3 | ||
| 12-1 Month Momentum % | 113.1 | ||
| 52-Week Range (₹) | 1175.5 - 3329 | ||
| Shares Outstanding (Mil) | 6.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NGL Fine-Chem Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NGL Fine-Chem Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 1.750000 Cash Dividend | 2026-08-18 | In 38 days | ||
| INR 1.750000 Cash Dividend | 2025-08-12 | 1,219.20 (-2.31%) | ||
| INR 1.750000 Cash Dividend | 2024-08-16 | 2,330.35 (+0.00%) |
Show
Entries
NGL Fine-Chem Ltd Frequently Asked Questions
What is NGL Fine-Chem Ltd(NSE:NGLFINE)'s stock price today?
The current price of NSE:NGLFINE is ₹3193.60. The 52 week high of NSE:NGLFINE is ₹3329.00 and 52 week low is ₹1175.50.
When is next earnings date of NGL Fine-Chem Ltd(NSE:NGLFINE)?
The next earnings date of NGL Fine-Chem Ltd(NSE:NGLFINE) is .
Does NGL Fine-Chem Ltd(NSE:NGLFINE) pay dividends? If so, how much?
The Dividend Yield %  of NGL Fine-Chem Ltd(NSE:NGLFINE) is 0.05% (As of Today), Highest Dividend Payout Ratio of NGL Fine-Chem Ltd(NSE:NGLFINE) was 0.11. The lowest was 0.02. And the median was 0.03. The  Forward Dividend Yield % of NGL Fine-Chem Ltd(NSE:NGLFINE) is 0.05%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on NGL Fine-Chem Ltd
No articles.